Immunic, Inc. (IMUX)
0.5337
+0.02
(+4.61%)
USD |
NASDAQ |
Dec 31, 16:00
0.5231
-0.01
(-1.99%)
After-Hours: 20:00
Immunic EPS Diluted (Quarterly): -0.1319 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aardvark Therapeutics, Inc. | -0.7503 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.58M |
| Total Expenses (Quarterly) | 25.58M |
| Enterprise Value | 29.86M |
| Earnings Yield | -162.2% |
| Normalized Earnings Yield | -162.17 |